Ocular Therapeutix (OCUL) Misses Q3 EPS by 1c

Ocular Therapeutix (NASDAQ: OCUL) reported Q3 EPS of ($0.38), $0.01 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $14.54 million versus the consensus estimate of $14.63 million.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

You May Also Be Interested In

• UBS sees a negative catalyst ahead for Nike: Here’s what to watch
• SpaceX Discusses Buying Data For Ai Models From Failed Startups - Bloomberg
• Jackson Financial Inc. (JXN) call put ratio 1 call to 14.6 puts with a focus on September 130 and 135 puts as share price down 4.8%